Silence Therapeutics (SLN) Return on Sales [ROS] (2024 - 2026)
Silence Therapeutics (SLN) recorded Return on Sales [ROS] of -11106.83% in the quarter ended Jun 30, 2026, down 409.06 percentage points from -10697.77% a year earlier and down 7377.68 percentage points from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Return on Sales [ROS] (2024 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Silence Therapeutics reported Return on Sales [ROS] of -16292.84%, down 16146.47 percentage points from the prior year.
- Annual Return on Sales [ROS] has a five-year change of -15638.58 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, Return on Sales [ROS] came in at -146.38% in the year ended Dec 31, 2024 (+48.19 pp), -194.56% in the year ended Dec 31, 2023 (+83.15 pp), -277.71% in the year ended Dec 31, 2022 (+91.31 pp) and -369.02% in the year ended Dec 31, 2021 (+285.24 pp).
- Quarterly Return on Sales [ROS] has ranged from -36650.00% in the quarter ended Dec 31, 2025 to -17.20% in the quarter ended Dec 31, 2024 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] rose in 1 of the last six quarters, with an average year-over-year change of -10502.15 percentage points.
- Per Business Quant, the preceding three quarters came in at -3729.15% (quarter ended Mar 31, 2026), -36650.00% (quarter ended Dec 31, 2025) and -16505.66% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Silence Therapeutics | 502.70 Mn | 430.60 Mn | - | -11,106.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11,106.83% |
| Mar 31, 2026 | -3,729.15% |
| Dec 31, 2025 | -36,650.00% |
| Sep 30, 2025 | -16,505.66% |
| Jun 30, 2025 | -10,697.77% |
| Mar 31, 2025 | -20,006.34% |
| Dec 31, 2024 | -17.20% |
| Sep 30, 2024 | -2,002.47% |
| Jun 30, 2024 | -2,923.50% |
| Mar 31, 2024 | -35.55% |
API Access
Silence Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();